Skip to main content

Follow our Journeys

Sharing success stories internal to Duke Capital Partners and external to our portfolio companies.

Headshot of Cambre Kelly toward the left of the image wearing a black shirt and smiling at the camera. To the right is the Reselute logotype of thicker sans serif lettering in gradient color from darker to lighter teal left to right. Background is an abstract burst of light colored lines in green and blue hues that highlight behind Kelly’s head and the Reselute logotype.

How the Partnership of a Duke Ph.D. and a Professor Led to Multiple Medical Device Start-Ups

Biomedical engineer Cambre Kelly is developing solutions for orthopedic surgeons through multiple companies co-founded with her thesis advisor, Duke Professor Ken Gall.

Read More about How the Partnership of a Duke Ph.D. and a Professor Led to Multiple Medical Device Start-Ups

MedTech Innovator logo up top, Sparta Biomedical logo below. Between, the words: "2023 Accelerator Cohort". White background.

Sparta Biomedical selected to MedTech Innovator 2023 Accelerator Cohort

Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, joins the world's largest medtech accelerator

Read More about Sparta Biomedical selected to MedTech Innovator 2023 Accelerator Cohort

restor3d and r3id logo

Custom surgical implant startup using AI lands 96 investors for $12M in new cash – WRALTechWire

restor3d is a Duke University orthopedic medical device start-up spun out of the lab of Professor Ken Gall (MEMS, Pratt).

Read More about Custom surgical implant startup using AI lands 96 investors for $12M in new cash – WRALTechWire

In foreground, from left to right: the Lacuna Medical logo on a transparent white paint splash, and a cut out headshot of Muath Bishawi. In the background, an abstract image of red and blue fluid.

Duke Surgical Resident is Building a Medical Device Company

Muath Bishawi M.D. Ph.D reflects on his innovation journey as his start-up, Lacuna Medical, receives seed financing led by Duke Capital Partners

Read More about Duke Surgical Resident is Building a Medical Device Company

tune tx nph announcement featured image

Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates

Tune Therapeutics is a Duke University start-up developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More about Tune Therapeutics Unveils Breakthrough Data Showing Stable and Durable Epigenetic Regulation in Non-Human Primates

Reselute logo on top, Duke Capital Partners logo below

Duke Capital Partners Leads Investment in Reselute

Reselute, founded around Duke technology by a Duke professor and graduates, is developing solutions to orthopedic infections

Read More about Duke Capital Partners Leads Investment in Reselute